Literature DB >> 11892052

Effects of allergic dermatosis on health-related quality of life.

R T Anderson1, R Rajagopalan.   

Abstract

Allergic dermatosis is a class of immunologic skin diseases manifested as intense itching, which potentially leads to a cycle of skin pain, damage, and infection. Information collected from clinical samples on health-related quality of life shows that some individuals may suffer from poor-quality sleep, physical and emotional distress, and limitations in social functioning. Although many individual factors may moderate the impact of disease on quality of life, disease severity is consistently linked to amount of limitation. There are only sparse data from population surveys in which participants are not selected based on willingness to join a treatment trial for relief of symptoms. This article presents quality-of-life and disease burden data on 559 persons in a community survey who reported signs and symptoms consistent with allergic dermatosis. Quality of life was assessed using the Dermatology-specific Quality of Life (DSQL) questionnaire. Overall, greater disease severity was associated with higher DSQL scores. Noticeable deficits were reported among those who rated their disease as moderate or severe, especially in terms of physical discomfort, sleep disturbance, and negative self-perceptions and emotions. These complaints correlated significantly with out-of-pocket expenses for lotions and emollients to control skin disease. Despite these complaints, the median number of days from the last primary healthcare visit was 453 days, indicating that many dermatosis sufferers are not accessing expert medical care that could alleviate distress.

Entities:  

Mesh:

Year:  2001        PMID: 11892052     DOI: 10.1007/s11882-001-0041-3

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  15 in total

1.  Results of a quality of life questionnaire in a patch test clinic population.

Authors:  D L Holness
Journal:  Contact Dermatitis       Date:  2001-02       Impact factor: 6.600

2.  The effect of skin disease on self image [proceedings].

Authors:  S Shuster; G H Fisher; E Harris; D Binnell
Journal:  Br J Dermatol       Date:  1978-07       Impact factor: 9.302

Review 3.  Measurement of disease activity and outcome in atopic dermatitis.

Authors:  A Y Finlay
Journal:  Br J Dermatol       Date:  1996-10       Impact factor: 9.302

4.  The impact of chronic urticaria on the quality of life.

Authors:  B F O'Donnell; F Lawlor; J Simpson; M Morgan; M W Greaves
Journal:  Br J Dermatol       Date:  1997-02       Impact factor: 9.302

5.  The use of decision-analytical modelling in economic evaluation of patch testing in allergic contact dermatitis.

Authors:  R Rajagopalan; R T Anderson; S Sarma; C Retchin; J Jones
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

6.  The profile of a patient with contact dermatitis and a suspicion of contact allergy (history, physical characteristics, and dermatology-specific quality of life).

Authors:  R Rajagopalan; R T Anderson
Journal:  Am J Contact Dermat       Date:  1997-03

7.  The extent and nature of disability in different urticarial conditions.

Authors:  E Poon; P T Seed; M W Greaves; A Kobza-Black
Journal:  Br J Dermatol       Date:  1999-04       Impact factor: 9.302

8.  An assessment of anxiety and dermatology life quality in patients with atopic dermatitis.

Authors:  J Linnet; G B Jemec
Journal:  Br J Dermatol       Date:  1999-02       Impact factor: 9.302

9.  A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life.

Authors:  W Czech; M Bräutigam; G Weidinger; E Schöpf
Journal:  J Am Acad Dermatol       Date:  2000-04       Impact factor: 11.527

10.  Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial.

Authors:  M S Salek; A Y Finlay; D K Luscombe; B R Allen; J Berth-Jones; R D Camp; R A Graham-Brown; G K Khan; R Marks; R J Motley
Journal:  Br J Dermatol       Date:  1993-10       Impact factor: 9.302

View more
  4 in total

1.  Health-care cost reduction resulting from primary-care allergy testing in children in Italy.

Authors:  Niklas Zethraeus; Carl Johan Petersson; Massimiliano Dozzi; Magnus P Borres; Giulio Vignati; Alessandro Fiocchi
Journal:  Ital J Pediatr       Date:  2010-09-13       Impact factor: 2.638

2.  Concordance Between Physician-rated and Caregiver-perceived Disease Severity in Children with Atopic Dermatitis: A Cross-sectional Study.

Authors:  Xiaomeng Xu; Maja Olsson; Ram Bajpai; Mark Koh Aan; Yik Weng Yew; Sharon Wong; Alice Foong; Steven Thng; Krister Järbrink; Josip Car
Journal:  Acta Derm Venereol       Date:  2020-11-04       Impact factor: 3.875

3.  Epidemiologic features and burden of atopic dermatitis in adolescent and adult patients: A cross-sectional multicenter study.

Authors:  Gloria Sanclemente; Natalia Hernandez; Daniela Chaparro; Liliana Tamayo; Angela Lopez
Journal:  World Allergy Organ J       Date:  2021-12-06       Impact factor: 4.084

Review 4.  Contact dermatitis.

Authors:  Pamela L Scheinman; Marc Vocanson; Jacob P Thyssen; Jeanne Duus Johansen; Rosemary L Nixon; Kate Dear; Nina C Botto; Johanna Morot; Ari M Goldminz
Journal:  Nat Rev Dis Primers       Date:  2021-05-27       Impact factor: 52.329

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.